Pediatric drug list inclusion via petition process will get expedited review -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
PEDIATRIC DRUG LIST INCLUSION THROUGH CITIZEN PETITION PROCESS will receive expedited consideration at FDA, Office of Chief Counsel attorney Elizabeth Dickinson told the Drug Information Association annual meeting in Boston June 10. "These petitions are identified as pediatric citizen's petitions. They will go through a special process. Generally they will get the thumbs-up, thumbs-down approach," she said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning